• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.天然产物放线菌素对M1家族氨肽酶的抑制作用的结构基础:与大肠杆菌氨肽酶N形成复合物的晶体结构
Protein Sci. 2015 May;24(5):823-31. doi: 10.1002/pro.2653. Epub 2015 Apr 8.
2
The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.四种与抗生素放线菌素结合的肽脱甲酰基酶的晶体结构揭示了两种不同类型:一种用于基于结构的抗菌剂设计的平台。
J Mol Biol. 2002 Jul 26;320(5):951-62. doi: 10.1016/s0022-2836(02)00549-1.
3
Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.羟胺类化合物作为有效的 Fe(II) 和 Mn(II)大肠杆菌甲硫氨酸氨肽酶抑制剂:唑基羟胺-EcMetAP-Mn 复合物的生物学活性和 X 射线结构。
ChemMedChem. 2012 Jun;7(6):1020-30. doi: 10.1002/cmdc.201200076. Epub 2012 Apr 4.
4
Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.新型肽脱甲酰基酶抑制剂BB - 3497的抗菌活性及特性
Antimicrob Agents Chemother. 2001 Feb;45(2):563-70. doi: 10.1128/AAC.45.2.563-570.2001.
5
Structural basis for the unusual specificity of Escherichia coli aminopeptidase N.大肠杆菌氨肽酶N异常特异性的结构基础。
Biochemistry. 2008 May 13;47(19):5303-11. doi: 10.1021/bi7022333. Epub 2008 Apr 17.
6
Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.放线诺宁是一种天然存在的抗菌剂,是一种有效的去甲酰化酶抑制剂。
Biochemistry. 2000 Feb 15;39(6):1256-62. doi: 10.1021/bi992245y.
7
X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17.一种口服可用的氨肽酶抑制剂托西司他与抗疟药物靶点PfA-M1和PfA-M17结合的X射线晶体结构。
Proteins. 2015 Apr;83(4):789-95. doi: 10.1002/prot.24771. Epub 2015 Feb 28.
8
Puromycin, a selective inhibitor of PSA acts as a substrate for other M1 family aminopeptidases: Biochemical and structural basis.嘌呤霉素,一种 PSA 的选择性抑制剂,可作为其他 M1 家族氨肽酶的底物:生化和结构基础。
Int J Biol Macromol. 2020 Dec 15;165(Pt A):1373-1381. doi: 10.1016/j.ijbiomac.2020.10.035. Epub 2020 Oct 9.
9
Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent solid-phase synthesis of tetrazole-peptidomimetics.通过四唑-肽模拟物的多组分固相合成发现对大肠埃希菌 M1-氨基肽酶的有效和选择性抑制剂。
Eur J Med Chem. 2019 Feb 1;163:481-499. doi: 10.1016/j.ejmech.2018.11.074. Epub 2018 Dec 1.
10
A naturally variable residue in the S1 subsite of M1 family aminopeptidases modulates catalytic properties and promotes functional specialization.M1 家族氨肽酶 S1 亚基中的一个自然变异残基调节催化特性并促进功能特化。
J Biol Chem. 2013 Sep 6;288(36):26004-26012. doi: 10.1074/jbc.M113.465625. Epub 2013 Jul 29.

引用本文的文献

1
Aminopeptidase N: a multifunctional and promising target in medicinal chemistry.氨肽酶N:药物化学中一个多功能且有前景的靶点。
RSC Adv. 2025 Jul 23;15(32):26455-26472. doi: 10.1039/d5ra03038b. eCollection 2025 Jul 21.
2
Investigation of Potential cGMP-Specific PDE V and Aminopeptidase N Inhibitors of L. and Its Bioactive Components: Kinetic and Molecular Docking Studies.L 的潜在 cGMP 特异性 PDE V 和氨肽酶 N 抑制剂及其生物活性成分的研究:动力学和分子对接研究。
Int J Mol Sci. 2023 Aug 28;24(17):13319. doi: 10.3390/ijms241713319.
3
Structure of puromycin-sensitive aminopeptidase and polyglutamine binding.嘌呤霉素敏感氨肽酶的结构与多聚谷氨酰胺结合。
PLoS One. 2023 Jul 13;18(7):e0287086. doi: 10.1371/journal.pone.0287086. eCollection 2023.
4
Inhibitors of BMP-1/tolloid-like proteinases: efficacy, selectivity and cellular toxicity.骨形态发生蛋白-1/类 tolloid 蛋白酶抑制剂:疗效、选择性及细胞毒性
FEBS Open Bio. 2018 Nov 12;8(12):2011-2021. doi: 10.1002/2211-5463.12540. eCollection 2018 Dec.
5
Aminobenzosuberone Scaffold as a Modular Chemical Tool for the Inhibition of Therapeutically Relevant M1 Aminopeptidases.基于氨苯并噻唑酮骨架的模块化化学工具抑制治疗相关 M1 氨肽酶。
Molecules. 2018 Oct 11;23(10):2607. doi: 10.3390/molecules23102607.
6
Small molecule inhibition of apicomplexan FtsH1 disrupts plastid biogenesis in human pathogens.小分子抑制顶复门 FtsH1 破坏人类病原体中的质体生物发生。
Elife. 2017 Aug 18;6:e29865. doi: 10.7554/eLife.29865.

本文引用的文献

1
Antibiotics in the clinical pipeline in 2013.2013 年临床研发中的抗生素。
J Antibiot (Tokyo). 2013 Oct;66(10):571-91. doi: 10.1038/ja.2013.86. Epub 2013 Sep 4.
2
A naturally variable residue in the S1 subsite of M1 family aminopeptidases modulates catalytic properties and promotes functional specialization.M1 家族氨肽酶 S1 亚基中的一个自然变异残基调节催化特性并促进功能特化。
J Biol Chem. 2013 Sep 6;288(36):26004-26012. doi: 10.1074/jbc.M113.465625. Epub 2013 Jul 29.
3
Identification, biochemical and structural evaluation of species-specific inhibitors against type I methionine aminopeptidases.鉴定、生化和结构评估针对 I 型甲硫氨酸氨肽酶的种属特异性抑制剂。
J Med Chem. 2013 Jul 11;56(13):5295-305. doi: 10.1021/jm400395p. Epub 2013 Jun 27.
4
Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.新型肽酰基转移酶抑制剂 GSK1322322 的抗菌活性比较分析。
Antimicrob Agents Chemother. 2013 May;57(5):2333-42. doi: 10.1128/AAC.02566-12. Epub 2013 Mar 11.
5
Metalloenzyme inhibitors for the treatment of Gram-negative bacterial infections: a patent review (2009-2012).用于治疗革兰氏阴性菌感染的金属酶抑制剂:专利审查(2009-2012)。
Expert Opin Ther Pat. 2013 Jul;23(7):777-88. doi: 10.1517/13543776.2013.777042. Epub 2013 Mar 4.
6
The X-ray crystal structure of human aminopeptidase N reveals a novel dimer and the basis for peptide processing.人氨肽酶 N 的 X 射线晶体结构揭示了一种新型二聚体和肽加工的基础。
J Biol Chem. 2012 Oct 26;287(44):36804-13. doi: 10.1074/jbc.M112.398842. Epub 2012 Aug 29.
7
Glu121-Lys319 salt bridge between catalytic and N-terminal domains is pivotal for the activity and stability of Escherichia coli aminopeptidase N.催化结构域和 N 端结构域之间的 Glu121-Lys319 盐桥对于大肠杆菌氨肽酶 N 的活性和稳定性至关重要。
Protein Sci. 2012 May;21(5):727-36. doi: 10.1002/pro.2060. Epub 2012 Mar 30.
8
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.LigPlot+:用于药物发现的多种配体-蛋白质相互作用图。
J Chem Inf Model. 2011 Oct 24;51(10):2778-86. doi: 10.1021/ci200227u. Epub 2011 Oct 5.
9
Features and development of Coot.Coot的特点与发展
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. doi: 10.1107/S0907444910007493. Epub 2010 Mar 24.
10
Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines.基质金属蛋白酶对原弹性蛋白的降解--切割位点特异性和细胞因子的释放。
FEBS J. 2010 Apr;277(8):1939-56. doi: 10.1111/j.1742-4658.2010.07616.x. Epub 2010 Mar 22.

天然产物放线菌素对M1家族氨肽酶的抑制作用的结构基础:与大肠杆菌氨肽酶N形成复合物的晶体结构

Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.

作者信息

Ganji Roopa Jones, Reddi Ravikumar, Gumpena Rajesh, Marapaka Anil Kumar, Arya Tarun, Sankoju Priyanka, Bhukya Supriya, Addlagatta Anthony

机构信息

Center for Chemical Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500007, Telangana, India.

出版信息

Protein Sci. 2015 May;24(5):823-31. doi: 10.1002/pro.2653. Epub 2015 Apr 8.

DOI:10.1002/pro.2653
PMID:25644575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4420530/
Abstract

Actinonin is a pseudotripeptide that displays a high affinity towards metalloproteases including peptide deformylases (PDFs) and M1 family aminopeptidases. PDF and M1 family aminopeptidases belong to thermolysin-metzincin superfamily. One of the major differences in terms of substrate binding pockets between these families is presence (in M1 aminopeptidases) or absence (in PDFs) of an S1 substrate pocket. The binding mode of actinonin to PDFs has been established previously; however, it is not clear how the actinonin, without a P1 residue, would bind to the M1 aminopeptidases. Here we describe the crystal structure of Escherichia coli aminopeptidase N (ePepN), a model protein of the M1 family aminopeptidases in complex with actinonin. For comparison we have also determined the structure of ePepN in complex with a well-known tetrapeptide inhibitor, amastatin. From the comparison of the actinonin and amastatin ePepN complexes, it is clear that the P1 residue is not critical as long as strong metal chelating head groups, like hydroxamic acid or α-hydroxy ketone, are present. Results from this study will be useful for the design of selective and efficient hydroxamate inhibitors against M1 family aminopeptidases.

摘要

放线菌素是一种假三肽,对包括肽脱甲酰基酶(PDFs)和M1家族氨肽酶在内的金属蛋白酶具有高亲和力。PDF和M1家族氨肽酶属于嗜热菌蛋白酶-金属锌蛋白酶超家族。这些家族在底物结合口袋方面的一个主要差异是S1底物口袋的存在(在M1氨肽酶中)或不存在(在PDFs中)。放线菌素与PDFs的结合模式先前已确定;然而,尚不清楚没有P1残基的放线菌素如何与M1氨肽酶结合。在此,我们描述了大肠杆菌氨肽酶N(ePepN)的晶体结构,它是M1家族氨肽酶的一种模型蛋白,与放线菌素形成复合物。为了进行比较,我们还确定了ePepN与一种著名的四肽抑制剂抑氨肽酶素形成复合物的结构。通过比较放线菌素和抑氨肽酶素与ePepN的复合物,可以清楚地看出,只要存在像异羟肟酸或α-羟基酮这样的强金属螯合头部基团,P1残基就不是关键的。这项研究的结果将有助于设计针对M1家族氨肽酶的选择性高效异羟肟酸抑制剂。